Details for New Drug Application (NDA): 202720
✉ Email this page to a colleague
The generic ingredient in MYCOPHENOLIC SODIUM is mycophenolic sodium. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mycophenolic sodium profile page.
Summary for 202720
Tradename: | MYCOPHENOLIC SODIUM |
Applicant: | Teva Pharms Usa |
Ingredient: | mycophenolic sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 180MG BASE | ||||
Approval Date: | Oct 30, 2014 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 360MG BASE | ||||
Approval Date: | Oct 30, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription